 American Renal Associates NYSE:ARA had its price objective reduced by SunTrust Banks from 10.00 to 8.00 in a research note issued to investors on Monday, BenzingaRatingsTable reports. They currently have a hold rating on the stock. A number of other brokerages also recently weighed in on ARA. Zacks Investment Research downgraded American Renal Associates from ... 